Obesity takes its toll on visceral pain: High-fat diet induces toll-like receptor 4-dependent visceral hypersensitivity

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Tramullas, Mónica ^a   Finger, Beate C ^b   Dinan, Timothy G ^a,b   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; LIPOPOLYSACCHARIDE; RESATORVID; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CELL ACTIVATION; CONTROLLED STUDY; EXPOSURE; HIPPOCAMPUS; LIPID DIET; MALE; MICROGLIA; MOUSE; NOCICEPTION; NONHUMAN; OBESITY; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPINAL CORD; SPLEEN; SPLEEN CELL; VISCERAL PAIN; WESTERN BLOTTING; ANIMAL; BRAIN; C57BL MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; DIET, HIGH-FAT; MALE; MICE; MICE, INBRED C57BL; OBESITY; TOLL-LIKE RECEPTOR 4; VISCERAL PAIN;

EID: 84969786165     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155367     Document Type: Article

References (74)

1. Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med. 2011; 62(361-80).
2. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006; 83(2):461S-5S. Epub 2006/02/14. PMID: 16470013.
3. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. Epub 2006/12/15.
4. Wieser V, Moschen AR, Tilg H. Inflammation, cytokines and insulin resistance: a clinical perspective. Arch Immunol Ther Exp (Warsz). 2013; 61(2):119-25. Epub 2013/01/12. doi: 10.1007/s00005-012-0210-1 PMID: 23307037.
5. Manna P, Jain SK. Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies. Metab Syndr Relat Disord. 2015; 13(10):423-44. Epub 2015/11/17. doi: 10.1089/met.2015.0095 PMID: 26569333.
6. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007; 56(7):1761-72. Epub 2007/04/26. doi: 10.2337/db06-1491 PMID: 17456850.
7. Cai D, Liu T. Hypothalamic inflammation: a double-edged sword to nutritional diseases. Ann N Y Acad Sci. 2011; 1243:E1-39. Epub 2012/03/16. doi: 10.1111/j.1749-6632.2011.06388.x PMID: 22417140.
8. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008; 57(6):1470-81. Epub 2008/02/29. doi: 10.2337/db07-1403.
9. Buckman LB, Hasty AH, Flaherty DK, Buckman CT, Thompson MM, Matlock BK, et al. Obesity induced by a high-fat diet is associated with increased immune cell entry into the central nervous system. Brain Behav Immun. 2014; 35:33-42. Epub 2013/07/09. doi: 10.1016/j.bbi.2013.06.007 PMID: 23831150; PubMed Central PMCID: PMC3858467.
10. Kim KA, Gu W, Lee IA, Joh EH, Kim DH. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One. 2012; 7(10):e47713. Epub 2012/10/24. doi: 10.1371/journal.pone.0047713 PMID: 23091640; PubMed Central PMCID: PMC3473013.
11. Pierre N, Deldicque L, Barbe C, Naslain D, Cani PD, Francaux M. Toll-like receptor 4 knockout mice are protected against endoplasmic reticulum stress induced by a high-fat diet. PLoS One. 2013; 8(5): e65061. Epub 2013/06/07. doi: 10.1371/journal.pone.0065061 PMID: 23741455; PubMed Central PMCID: PMC3669084.
12. Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci. 2009; 29(2):359-70. doi: 10.1523/JNEUROSCI.2760-08.2009 PMID: 19144836
13. Lee JY, Sohn KH, Rhee SH, Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. The Journal of biological chemistry. 2001; 276(20):16683-9. Epub 2001/03/30. doi: 10.1074/jbc.M011695200 PMID: 11278967.
14. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. The Journal of clinical investigation. 2006; 116(11):3015-25. Epub 2006/10/21. doi: 10.1172/JCI28898 PubMed Central PMCID: PMC1616196.
15. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A. 2003; 100(14):8514-9. PMID: 12824464
16. Graeber MB. Changing face of microglia. Science. 2010; 330(6005):783-8. doi: 10.1126/science.1190929 PMID: 21051630
17. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes. 2007; 56(8):1986-98. Epub 2007/05/24. db06-1595 [pii] doi: 10.2337/db06-1595 PMID: 17519423.
18. Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring). 2008; 16(6):1248-55. Epub 2008/04/19. doi: 10.1038/oby.2008.210.
19. Tramullas M, Finger BC, Moloney RD, Golubeva AV, Moloney G, Dinan TG, et al. Toll-like receptor 4 regulates chronic stress-induced visceral pain in mice. Biol Psychiatry. 2014; 76(4):340-8. Epub 2013/12/18. doi: 10.1016/j.biopsych.2013.11.004 PMID: 24331544.
20. O' Mahony SM, Clarke G, McKernan DP, Bravo JA, Dinan TG, Cryan JF. Differential visceral nociceptive, behavioural and neurochemical responses to an immune challenge in the stress-sensitive Wistar Kyoto rat strain. Behav Brain Res. 2013; 253:310-7. Epub 2013/07/23. doi: 10.1016/j.bbr.2013.07.023 PMID: 23872358.
21. Das V. An introduction to pain pathways and pain "targets". Prog Mol Biol Transl Sci. 2015; 131:1-30. Epub 2015/03/07. doi: 10.1016/bs.pmbts.2015.01.003.
22. Finger BC, Dinan TG, Cryan JF. High-Fat Diet Selectively Protects Against the Effects of Chronic Social Stress in the Mouse. Neuroscience. 2011; 192:351-60. doi: 10.1016/j.neuroscience.2011.06.072 PMID: 21742017
23. Finger BC, Dinan TG, Cryan JF. The temporal impact of chronic intermittent psychosocial stress on high-fat diet-induced alterations in body weight. Psychoneuroendocrinology. 2012; 37(6):729-41. Epub 2011/07/26. doi: 10.1016/j.psyneuen.2011.06.015 PMID: 21783325.
24. Christianson JA, Gebhart GF. Assessment of colon sensitivity by luminal distension in mice. Nat Protoc. 2007; 2(10):2624-31. PMID: 17948005
25. Ness TJ, Metcalf AM, Gebhart GF. A psychophysiological study in humans using phasic colonic distension as a noxious visceral stimulus. Pain. 1990; 43(3):377-86. PMID: 2293146
26. O'Mahony SM, Tramullas M, Fitzgerald P, Cryan JF. Rodent models of colorectal distension. Curr Protoc Neurosci. 2012;Chapter 9:Unit 9 40. Epub 2012/10/25. doi: 10.1002/0471142301.ns0940s61.
27. Tramullas M, Dinan TG, Cryan JF. Chronic psychosocial stress induces visceral hyperalgesia in mice. Stress. 2012; 15(3):281-92. Epub 2011/10/14. doi: 10.3109/10253890.2011.622816 PMID: 21992065.
28. Arvidsson S, Larsson M, Larsson H, Lindstrom E, Martinez V. Assessment of visceral pain-related pseudo-affective responses to colorectal distension in mice by intracolonic manometric recordings. J Pain. 2006; 7(2):108-18. Epub 2006/02/07. S1526-5900(05)00851-5 [pii] doi: 10.1016/j.jpain.2005.09.003 PMID: 16459276.
29. Tammpere A, Brusberg M, Axenborg J, Hirsch I, Larsson H, Lindstrom E. Evaluation of pseudo-affective responses to noxious colorectal distension in rats by manometric recordings. Pain. 2005; 116(3):220-6. Epub 2005/06/07. S0304-3959(05)00180-6 [pii].
30. Matsunaga N, Tsuchimori N, Matsumoto T, Ii M. TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol Pharmacol. 2011; 79(1):34-41. doi: 10.1124/mol.110.068064
31. Tramullas M, Lantero A, Díaz A, Morchón N, Merino D, Villar A, et al. BAMBI (bone morphogenetic protein and activin membrane-bound inhibitor) reveals the involvement of the transforming growth factorbeta family in pain modulation. J Neurosci. 2010; 30(4):1502-11. doi: 10.1523/JNEUROSCI.2584-09.2010
32. Guilford BL, Ryals JM, Wright DE. Phenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice. Exp Diabetes Res. 2011; 2011:848307. Epub 2011/12/07. doi: 10.1155/2011/848307 PMID: 22144990; PubMed Central PMCID: PMC3226416.
33. Obrosova IG, Ilnytska O, Lyzogubov VV, Pavlov IA, Mashtalir N, Nadler JL, et al. High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition. Diabetes. 2007; 56(10):2598-608. Epub 2007/07/14. doi: 10.2337/db06-1176.
34. Lorenz J, Minoshima S, Casey KL. Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain. 2003; 126(Pt 5):1079-91. Epub 2003/04/12. PMID: 12690048.
35. Raghavendra V, Tanga FY, DeLeo JA. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci. 2004; 20(2):467-73. Epub 2004/07/06. [pii].
36. Sorge RE, LaCroix-Fralish ML, Tuttle AH, Sotocinal SG, Austin JS, Ritchie J, et al. Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice. J Neurosci. 2011; 31(43):15450-4. Epub 2011/10/28. 31/43/15450 [pii] doi: 10.1523/JNEUROSCI.3859-11.2011 PMID: 22031891; PubMed Central PMCID: PMC3218430.
37. Tanga FY, Nutile-McMenemy N, DeLeo JA. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A. 2005; 102(16):5856-61. PMID: 15809417
38. Wu FX, Bian JJ, Miao XR, Huang SD, Xu XW, Gong DJ, et al. Intrathecal siRNA against Toll-like receptor 4 reduces nociception in a rat model of neuropathic pain. Int J Med Sci. 2010; 7(5):251-9. Epub 2010/08/18. PMID: 20714435; PubMed Central PMCID: PMC2920570.
39. Pan R, Di H, Zhang J, Huang Z, Sun Y, Yu W, et al. Inducible Lentivirus-Mediated siRNA against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain. Mediators Inflamm. 2015; 2015:523896. Epub 2015/11/12. doi: 10.1155/2015/523896 PMID: 26556957; PubMed Central PMCID: PMC4628653.
40. Schomberg D, Olson JK. Immune responses of microglia in the spinal cord: Contribution to pain states. Exp Neurol. 2011. Epub 2012/01/10. S0014-4886(11)00473-0 [pii] doi: 10.1016/j.expneurol.2011.12.021 PMID: 22226600.
41. Vallejo R, Tilley DM, Vogel L, Benyamin R. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract. 2010; 10(3):167-84. Epub 2010/04/14. PPR367 [pii] doi: 10.1111/j.1533-2500.2010.00367.x PMID: 20384965.
42. Golovatscka V, Ennes H, Mayer EA, Bradesi S. Chronic stress-induced changes in pro-inflammatory cytokines and spinal glia markers in the rat: a time course study. Neuroimmunomodulation. 2012; 19(6):367-76. Epub 2012/10/12. PubMed Central PMCID: PMC3535433.
43. Groover AL, Ryals JM, Guilford BL, Wilson NM, Christianson JA, Wright DE. Exercise-mediated improvements in painful neuropathy associated with prediabetes in mice. Pain. 2013; 154(12):2658-67. Epub 2013/08/13. PubMed Central PMCID: PMC3844098.
44. Vincent AM, Hayes JM, McLean LL, Vivekanandan-Giri A, Pennathur S, Feldman EL. Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes. 2009; 58(10):2376-85. Epub 2009/07/14. doi: 10.2337/db09-0047 PubMed Central PMCID: PMC2750230.
45. Grabauskas G, Heldsinger A, Wu X, Xu D, Zhou S, Owyang C. Diabetic visceral hypersensitivity is associated with activation of mitogen-activated kinase in rat dorsal root ganglia. Diabetes. 2011; 60(6):1743-51. Epub 2011/04/26. doi: 10.2337/db10-1507 PMID: 21515848; PubMed Central PMCID: PMC3114390.
46. Caruana BJ, Wald A, Hinds JP, Eidelman BH. Anorectal sensory and motor function in neurogenic fecal incontinence. Comparison between multiple sclerosis and diabetes mellitus. Gastroenterology. 1991; 100(2):465-70. Epub 1991/02/01. PMID: 1985043.
47. Mayer EA, Naliboff BD, Craig AD. Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders. Gastroenterology. 2006; 131(6):1925-42. PMID: 17188960
48. Wang Z, Guo Y, Bradesi S, Labus JS, Maarek JM, Lee K, et al. Sex differences in functional brain activation during noxious visceral stimulation in rats. Pain. 2009; 145(1-2):120-8.
49. Gibney SM, Gosselin RD, Dinan TG, Cryan JF. Colorectal distension-induced prefrontal cortex activation in the Wistar-Kyoto rat: implications for irritable bowel syndrome. Neuroscience. 2010; 165(3):675-83. doi: 10.1016/j.neuroscience.2009.08.076
50. Bradesi S. Role of spinal cord glia in the central processing of peripheral pain perception. Neurogastroenterol Motil. 2010; 22(5):499-511. Epub 2010/03/20. NMO1491 [pii] doi: 10.1111/j.1365-2982.2010.01491.x PMID: 20236247; PubMed Central PMCID: PMC2893561.
51. Gosselin RD, O'Connor RM, Tramullas M, Julio-Pieper M, Dinan TG, Cryan JF. Riluzole normalizes early-life stress-induced visceral hypersensitivity in rats: role of spinal glutamate reuptake mechanisms. Gastroenterology. 2010; 138(7):2418-25. Epub 2010/03/17. doi: 10.1053/j.gastro.2010.03.003 PMID: 20226190.
52. Wang YS, Li YY, Wang LH, Kang Y, Zhang J, Liu ZQ, et al. Tanshinone IIA Attenuates Chronic Pancreatitis-Induced Pain in Rats via Downregulation of HMGB1 and TRL4 Expression in the Spinal Cord. Pain Physician. 2015; 18(4):E615-28. Epub 2015/07/29. 26218952. PMID: 26218952
53. Lin JJ, Du Y, Cai WK, Kuang R, Chang T, Zhang Z, et al. Toll-like receptor 4 signaling in neurons of trigeminal ganglion contributes to nociception induced by acute pulpitis in rats. Sci Rep. 2015; 5:12549. Epub 2015/08/01. doi: 10.1038/srep12549 PMID: 26224622; PubMed Central PMCID: PMC4519790.
54. Li Y, Zhang H, Kosturakis AK, Cassidy RM, Kennamer-Chapman RM, Jawad AB, et al. MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy. Brain Behav Immun. 2015; 49:255-66. Epub 2015/06/13. doi: 10.1016/j.bbi.2015.06.003 PMID: 26065826; PubMed Central PMCID: PMC4567501.
55. Bradesi S, Svensson CI, Steinauer J, Pothoulakis C, Yaksh TL, Mayer EA. Role of spinal microglia in visceral hyperalgesia and NK1R up-regulation in a rat model of chronic stress. Gastroenterology. 2009; 136(4):13339-48.
56. Liu PY, Lu CL, Wang CC, Lee IH, Hsieh JC, Chen CC, et al. Spinal microglia initiate and maintain hyperalgesia in a rat model of chronic pancreatitis. Gastroenterology. 2012; 142(1):165-73 e2. Epub 2011/10/04. S0016-5085(11)01366-7 [pii] doi: 10.1053/j.gastro.2011.09.041 PMID: 21963786.
57. Shubayev VI, Kato K, Myers RR. Cytokines in Pain. In: Kruger L, Light AR, editors. Translational Pain Research: From Mouse to Man. Frontiers in Neuroscience. Boca Raton, FL 2010.
58. Nicotra L, Loram LC, Watkins LR, Hutchinson MR. Toll-like receptors in chronic pain. Exp Neurol. 2012; 234(2):316-29. Epub 2011/10/18. doi: 10.1016/j.expneurol.2011.09.038 PMID: 22001158; PubMed Central PMCID: PMC3303935.
59. Dogukan A, Tuzcu M, Juturu V, Cikim G, Ozercan I, Komorowski J, et al. Effects of chromium histidinate on renal function, oxidative stress, and heat-shock proteins in fat-fed and streptozotocin-treated rats. J Ren Nutr. 2010; 20(2):112-20. Epub 2009/07/21. doi: 10.1053/j.jrn.2009.04.009 PMID: 19616452.
60. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. The Journal of biological chemistry. 2002; 277(17):15028-34. PMID: 11836257
61. de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. Propensity to high-fat dietinduced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 2010; 299(2):G440-8. Epub 2010/05/29. doi: 10.1152/ajpgi.00098.2010 PMID: 20508158; PubMed Central PMCID: PMC2928532.
62. Murphy EF, Cotter PD, Healy S, Marques TM, O'Sullivan O, Fouhy F, et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut. 2010; 59(12):1635-42. Epub 2010/10/12. doi: 10.1136/gut.2010.215665 PMID: 20926643.
63. Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NM, Magness S, et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One. 2010; 5(8):e12191. Epub 2010/09/03. doi: 10.1371/journal.pone.0012191 PMID: 20808947; PubMed Central PMCID: PMC2922379.
64. Clarke SF, Murphy EF, O'Sullivan O, Ross RP, O'Toole PW, Shanahan F, et al. Targeting the microbiota to address diet-induced obesity: a time dependent challenge. PLoS One. 2013; 8(6):e65790. Epub 2013/06/14. doi: 10.1371/journal.pone.0065790 PMID: 23762426; PubMed Central PMCID: PMC3676335.
65. London LE, Kumar AH, Wall R, Casey PG, O'Sullivan O, Shanahan F, et al. Exopolysaccharide-producing probiotic Lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient mice. J Nutr. 2014; 144(12):1956-62. Epub 2014/10/17. doi: 10.3945/jn.114.191627 PMID: 25320181.
66. McAllan L, Skuse P, Cotter PD, O'Connor P, Cryan JF, Ross RP, et al. Protein quality and the protein to carbohydrate ratio within a high fat diet influences energy balance and the gut microbiota in C57BL/6J mice. PLoS One. 2014; 9(2):e88904. Epub 2014/02/13. doi: 10.1371/journal.pone.0088904 PMID: 24520424; PubMed Central PMCID: PMC3919831.
67. Chan YK, Estaki M, Gibson DL. Clinical consequences of diet-induced dysbiosis. Ann Nutr Metab. 2013; 63 Suppl 2:28-40. Epub 2013/11/15. doi: 10.1159/000354902.
68. Clarke G, Cryan JF, Dinan TG, Quigley EM. Review article: probiotics for the treatment of irritable bowel syndrome - focus on lactic acid bacteria. Aliment Pharmacol Ther. 2012; 35(4):403-13. Epub 2012/01/10. doi: 10.1111/j.1365-2036.2011.04965.x.
69. Quigley EM. The efficacy of probiotics in IBS. J Clin Gastroenterol. 2008; 42 Suppl 2:S85-90. Epub 2008/06/11.
70. Verdu EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut. 2006; 55(2):182-90. Epub 2005/08/18. doi: 10.1136/gut.2005.066100 PMID: 16105890; PubMed Central PMCID: PMC1856497.
71. McKernan DP, Fitzgerald P, Dinan TG, Cryan JF. The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil. 2010; 22(9):1029-35, e268. Epub 2010/06/04. doi: 10.1111/j.1365-2982.2010.01520.x PMID: 20518856.
72. Zhao Y, Xin Y, Gao J, Teng RY, Chu HC. Analgesic effect of TAK-242 on neuropathic pain in rats. Int J Clin Exp Med. 2015; 8(7):11202-7. Epub 2015/09/18. PMID: 26379924; PubMed Central PMCID: PMC4565307.
73. Bettoni I, Comelli F, Rossini C, Granucci F, Giagnoni G, Peri F, et al. Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia. 2008; 56(12):1312-9. Epub 2008/07/11. doi: 10.1002/glia.20699 PMID: 18615568.
74. Hutchinson MR, Zhang Y, Brown K, Coats BD, Shridhar M, Sholar PW, et al. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur J Neurosci. 2008; 28(1):20-9. Epub 2008/07/30. EJN6321 [pii] doi: 10.1111/j.1460-9568.2008.06321.x PubMed Central PMCID: PMC2588470.